Adial Pharmaceuticals Inc... (ADILW)
NASDAQ: ADILW
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Jul 27, 2023, 9:52 PM
Adial Pharmaceuticals WT EXP 073123 Ratios and Metrics
Financials in USD. Fiscal
year is
undefined.
Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -2.27 | -0.66 | -0.46 | -0.14 | -0.4 | -0.59 | 1.37 | -0.8 | -0.51 | -0.74 | -2.11 | -4.22 | -2.38 | -4.93 | -2.52 | -1.99 |
PEG Ratio | 0.03 | 0.02 | 0.01 | -0.00 | 0.16 | 0.00 | -0.01 | -0.54 | 0.06 | 0.03 | -0.06 | 0.07 | -0.08 | 0.36 | 0.15 | -0.08 |
PS Ratio | n/a | n/a | n/a | n/a | 95.95 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 4.62 | 0.99 | 1.07 | 0.59 | 0.76 | 1.40 | 1.79 | 6.43 | 1.79 | 1.66 | 4.09 | 4.35 | 15.80 | 11.83 | 9.29 | 6.85 |
P/FCF Ratio | -12.91 | -3.44 | -2.12 | -2.23 | -2.53 | -2.36 | -3.14 | -4.03 | -3.35 | -2.65 | -9.22 | -18.64 | -0.00 | -24.12 | -13.86 | -13.4 |
P/OCF Ratio | -12.91 | -3.44 | -2.12 | -2.23 | -2.53 | -2.36 | -3.14 | -4.03 | -3.35 | -2.65 | -9.22 | -18.64 | -23.36 | -24.12 | -14 | -13.54 |
OCF/S Ratio | n/a | n/a | n/a | n/a | -37.91 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.13 | 0.06 | 0.04 | 0.03 | 0.02 | 0.07 | 0.04 | 0.06 | 0.06 |
Quick Ratio | 4.16 | 6.78 | 5.69 | 9.48 | 4.90 | 2.15 | 4.43 | 1.65 | 2.67 | 5.10 | 5.32 | 5.97 | 2.37 | 4.08 | 2.53 | 3.02 |
Current Ratio | 4.16 | 6.78 | 5.69 | 9.48 | 4.90 | 2.15 | 4.43 | 1.65 | 2.67 | 5.10 | 5.32 | 5.97 | 2.37 | 4.08 | 2.53 | 3.02 |
Asset Turnover | n/a | n/a | n/a | n/a | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | -119.79 | n/a | n/a | n/a | n/a | n/a | -224.4 | n/a | -31.79 | n/a | n/a | n/a |
Return on Equity | -0.51 | -0.37 | -0.57 | -1.06 | -0.47 | -0.59 | 0.33 | -2.01 | -0.87 | -0.56 | -0.49 | -0.26 | -1.66 | -0.6 | -0.92 | -0.86 |
Return on Assets | -0.41 | -0.33 | -0.5 | -0.97 | -0.41 | -0.48 | 0.29 | -0.74 | -0.5 | -0.39 | -0.35 | -0.2 | -0.78 | -0.41 | -0.55 | -0.56 |
Return on Invested Capital | -0.48 | -0.38 | -0.53 | -0.3 | -0.44 | -0.6 | 0.32 | -1.34 | -0.8 | -0.48 | -0.42 | -0.24 | -1.23 | -0.5 | -0.75 | -0.73 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | 1.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | -59.55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | -59.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | -55.32 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | -59.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |